SpaceX Stock Has Begun Trading on the Nasdaq at $150. Here's Why Investors Are Bidding Up the Share Price.

SpaceX began public trading at $150/share after its $135 IPO, briefly reaching $168-$172 intraday and implying a $2 trillion market cap. The article highlights unusually heavy retail demand, a hotly contested valuation, and sharply divergent analyst targets ranging from $63 to $190 per share. Near-term trading is portrayed as highly volatile, with long-term performance still unclear.

Analysis

The first-order move is mostly a plumbing event, not a fundamental re-rating. When a scarce deal is opened to retail and then immediately tradable across cash and derivatives, the initial print tends to overshoot intrinsic value because the marginal buyer is driven by allocation regret rather than discounted cash flow. That creates a rich environment for short-dated volatility selling, but only after the opening imbalance is absorbed and borrow becomes available.

The more interesting second-order effect is on the capital-allocation ecosystem around the name. A marquee debut with outsized retail participation can temporarily siphon attention and liquidity from other high-beta growth proxies, especially names whose valuation depends on the same “future optionality” narrative; that likely creates relative-discount opportunities in profitable, execution-oriented analogs. In other words, the trade is less about owning the obvious hero and more about fading the crowded expression of the theme once the first wave of enthusiasm cools.

The analyst spread is telling: the market is not pricing a single business, it is pricing a bundle of call options on launch cadence, connectivity, AI adjacency, and governance tolerance. The real tail risk is that any one of those narratives disappoints and compresses the whole multiple together, because the stock has no margin of safety if investors decide the story is worth less than the sum of its parts. That makes the next 1-3 months a positioning contest, while the next 12-24 months will be governed by whether the business can convert optionality into recurring, high-quality cash flow.

Contrarianly, the consensus may be underestimating how quickly “greatest-ever IPO” psychology can invert once post-listing supply normalizes. If the stock remains elevated, secondary selling, insider monetization expectations, and systematic volatility targeting can create self-reinforcing downside. The better entry is likely after the first full earnings cycle, when the market can distinguish narrative premium from actual unit economics.

Key Decisions for Investors

• Avoid initiating outright longs in NDAQ-linked IPO-adjacent excitement for the next 5-10 trading days; let first-week volatility and any secondary supply flush through before reassessing.
• Look for a tactical short in MORN on strength over the next 1-4 weeks: the stock-screening ecosystem loses attention when a mega-speculative IPO dominates retail flows, and the name is more exposed to sentiment normalization than to any fundamental shock.
• Relative-value: long TSLA / short high-multiple, unprofitable aerospace-growth proxies for 1-3 months if the market keeps paying for founder optionality; TSLA should be less vulnerable to a post-IPO de-risking than names with weaker recurring revenue.
• If options liquidity is sufficient, sell 2-6 week strangles or iron condors on the new listing only after the opening range stabilizes; implied volatility should stay elevated, and the edge is in mean reversion rather than direction.
• For longer horizon capital, prefer wait-and-see until the first post-listing earnings update; any drawdown of 15-25% from opening levels would be the first point where risk/reward becomes investable rather than narrative-driven.